Post-exposure antibody treatment protects primates from Ebola, Marburg viruses
Army scientists have demonstrated, for the first time, that antibody-based therapies can successfully protect monkeys from the deadly Ebola and Marburg viruses. In addition, the animals were fully protected even when treatment was administered two days post-infection, an accomplishment unmatched by any experimental therapy for these viruses to date. The work appears in this week's electronic edition of Proceedings of the National Academy of Sciences.
The filoviruses, Ebola and Marburg, cause hemorrhagic fever with human case fatality rates as high as 90 percent. They are a global health concern and are considered potential biological threat agents. Currently there are no available vaccines or therapies approved for use in humans, making the development of such products a high priority.
In the article, John M. Dye, Andrew S. Herbert, William D. Pratt, and colleagues from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) describe using antibody from monkeys that had previously survived challenge with lethal doses of filoviruses under controlled laboratory conditions. These survivors had developed high levels of antibody to ward off disease. Investigators collected blood serum from these animals, purified it and tested it for virus-neutralizing activity before commencing with their work.
In the first study, monkeys infected with Marburg virus were treated with antibody 15 to 30 minutes post-exposure, with additional treatments on days 4 and 8. The animals were completely protected, with no signs of disease or detectable levels of virus in their bloodstreams. Furthermore, all the monkeys generated an immune response to Marburg virus and survived subsequent re-challenge with the virus.
In the next set of studies, monkeys were infected with either Ebola or Marburg virus and treatments were delayed 48 hours, with additional treatments on days 4 and 8 post-exposure. The delayed treatments protected both sets of animals from challenge. In each group, two of the three animals had no clinical signs of illness following treatment, with the third developing mild symptoms followed by full recovery.
For nearly a decade, the filovirus research community has disregarded antibody-based therapies due to numerous failed attempts to protect monkeys against filovirus challenge, according to Dye.
"The use of antibodies as a treatment for infectious diseases is a well-established technology, with multiple products having received approval from the Food and Drug Administration," said Dye. "With these findings, we have provided proof-of concept that antibody-based therapies can indeed be used to effectively treat filovirus infections."
Dye said the USAMRIID team is hopeful that its work will open new avenues for development of filovirus therapies for human use.
More information: Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease. John M. Dye, Andrew S. Herbert, Ana I. Kuehne, James F. Barth, Majidat A. Muhammad, Samantha E. Zak, Ramon A. Ortiz, Laura I. Prugar, and William D. Pratt: PNAS Early Edition. Published online at www.pnas.org/cgi/d… s.1200409109
Journal reference: Proceedings of the National Academy of Sciences
Provided by US Army Medical Research Institute of Infectious Diseases
- Combination vaccine protects monkeys from ebola and Marburg viruses Feb 26, 2008 | not rated yet | 0
- Novel 'antisense' therapies protect primates from lethal Ebola and Marburg viruses Aug 22, 2010 | not rated yet | 0
- Experimental Marburg vaccine prevents disease 2 days after infection Jun 16, 2010 | not rated yet | 0
- Experimental treatment protects monkeys from lethal Ebola virus post-exposure May 27, 2010 | not rated yet | 0
- Research team identifies receptor for Ebola virus May 02, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
7 hours ago Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.
Medical research 1 hour ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...
Medical research 2 hours ago | 5 / 5 (1) | 0 |
(Medical Xpress)—According to the World Health Organization, approximately 70 million couples experience infertility worldwide. Current data suggests that nearly one third of infertility disorders are due ...
Medical research 3 hours ago | 5 / 5 (1) | 0
Every day, their baby stopped breathing, his collapsed bronchus blocking the crucial flow of air to his lungs. April and Bryan Gionfriddo watched helplessly, just praying that somehow the dire predictions ...
Medical research 18 hours ago | 5 / 5 (3) | 0
The human gut is loaded with commensal bacteria – "good" microbes that, among other functions, help the body digest food. The gastrointestinal tract contains literally trillions of such cells, and yet the ...
Medical research 22 hours ago | 5 / 5 (3) | 0 |
A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...
20 minutes ago | not rated yet | 0 |
Nervous about that upcoming job interview? You might want to take steps to reduce your jitters, especially if you are a man.
6 minutes ago | not rated yet | 0
22 May 2013, Paris, France: The Lotus Valve, a second-generation transcatheter aortic valve implantation (TAVI) device, was successfully implanted in all of the first 60 patients in results from REPRISE II reported at EuroPCR ...
22 minutes ago | not rated yet | 0
A potentially ground-breaking human drug trial is currently underway, which aims to discover whether blood pressure medication can slow or halt the progression of Alzheimer's Disease (AD). This is the latest ...
30 minutes ago | not rated yet | 0
Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.
1 hour ago | 5 / 5 (1) | 0 |
(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...
2 hours ago | not rated yet | 0 |